ENTA vs IEX · rev $65.3M vs P/E 29, rev $1.81B
Enanta Pharmaceuticals Inc (ENTA) versus IDEX Corporation (IEX) — a side-by-side from cached financials, not a winner call.
Enanta Pharmaceuticals Inc (ENTA) is a biotechnology company listed on US.
IDEX Corporation (IEX) is a specialty industrial machinery company listed on US.
Latest reported ENTA revenue for 2025-09-30 was $65.3M. Net income was -$81.9M. ENTA currently screens at market cap $328.0M.
Latest reported IEX revenue for 2026-06-30 was $1.81B. Net income was $263.4M. IEX currently screens at market cap $13.71B and trailing P/E 28.8.
ENTA currently screens at market cap $328.0M. IEX currently screens at market cap $13.71B and trailing P/E 28.8.
Not investment advice. Open the ENTA and IEX stock pages for the full models.
Not investment advice.